Personalizing dermatology: The future of genomic expression profiling to individualize dermatologic therapy

References

• Jarrold BB, Mullins LA, Reichling TD, Tiesmann JP, Juhlin KD, Binder RL, Genomics analysis of expression of stratum corneum lipid metabolism pathways associated with aging and responses to cosmetic ingredients. Exp Dermatol. 2010;19(2):222.
   Google Scholar
• Bauer JW, Laimer M. Gene therapy of epidermolysis bullosa. Expert Opin Biol Ther. 2004;4(9):1435–1443.
   PubMedGoogle Scholar
• Liu Y, Krueger JG, Bowcock AM. Psoriasis: Genetic associations and immune system changes. Genes Immun. 2007;8(1):1–12.
   PubMedGoogle Scholar
• Courtesy: National Human Genome Research Institute (NHGRI). Funding History, genome.gov. November 12, 2009 [last updated February 4, 2008]. Available from: http://www.genome.gov/Pages/About/Budget/FundingHistory90-09.pdf.
   Google Scholar
• Guttmacher AE, Collins FS. Genomic medicine—a primer. N Engl J Med. 2002;347(19):1512–1520.
   PubMedGoogle Scholar
• Lee C, Morton CC. Structural genomic variation and personalized medicine. N Engl J Med. 2008;358(7):740–741.
   PubMedGoogle Scholar
• Stein LD. Human genome: End of the beginning. Nature. 2004;431(7011):915–916.
   PubMed Web of Science ®Google Scholar
• Romero PR, Zaidi S, Fang YY, Uversky VN, Radivojac P, Oldfield CJ, Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms. Proc Natl Acad Sci U S A. 2006;103(22):8390–8395.
   PubMedGoogle Scholar
• Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 2001;409(6822):928–933.
   PubMedGoogle Scholar
• Courtesy: National Library of Medicine (NCBI). Single Nucleotide Polymorphism, ncbi.nlm.nih.gov. November 10, 2009 [last updated December 30, 2008]. URL: http://www.ncbi.nlm.nih.gov/SNP.
   Google Scholar
• Courtesy: National Human Genome Research Institute (NHGRI). International HapMap Project, genome.gov. November 07, 2009 [last updated September 10, 2009]. URL: http://www.genome.gov/Pages/Research/HapMap.
   Google Scholar
• Couzin J. Human genome. HapMap launched with pledges of $100 million. Science. 2002;298(5595):941–942.
   PubMedGoogle Scholar
• Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270(5235):467–470.
   PubMed Web of Science ®Google Scholar
• Duyk GM. Sharper tools and simpler methods. Nat Genet. 2002;32(suppl):465–468.
   PubMedGoogle Scholar
• Holloway AJ, van Laar RK, Tothill RW, Bowtell DD. Options available—from start to finish—for obtaining data from DNA microarrays II. Nat Genet. 2002;32(suppl):481–489.
   PubMedGoogle Scholar
• Petricoin EF 3rd, Hackett JL, Lesko LJ, Puri RK, Gutman SI, Chumakov K, Medical applications of microarray technologies: A regulatory science perspective. Nat Genet. 2002;32(suppl):474–479.
   PubMedGoogle Scholar
• Quackenbush J. Microarray data normalization and transformation. Nat Genet. 2002;32(suppl):496–501.
   PubMedGoogle Scholar
• Trent JM, Baxevanis AD. Chipping away at genomic medicine. Nat Genet. 2002;32:462.
   Google Scholar
• Perkel JM. Molecular diagnostics: Personalizing personalized medicine. Science. 2009;324(5928):815–817.
   Google Scholar
• Courtesy: U.S. Food and Drug Administration. Table of Valid Genomic Biomarkers in the Context of Approved Drug Labels, fda.gov. November 5, 2009 [last updated August 18, 2008]. URL: http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm.
   Google Scholar
• Wang L, Weinshilboum R. Thiopurine S-methyltransferase pharmacogenetics: Insights, challenges and future directions. Oncogene. 2006;25:1629–1638.
   PubMed Web of Science ®Google Scholar
• Salavaggione O E, Wang L, Wiepert M, Yee VC, Weinshilboum RM. Thiopurine S-methyltransferase pharmacogenetics: Variant allele functional and comparative genomics. Pharmacogenet Genomics. 2005;15:801–815.
   PubMedGoogle Scholar
• U.S. Department of Health and Human Services Food and Drug Administration. Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research & Center for Devices and Radiological Health. November 2003. Available at: http://www.FDA.gov.
   Google Scholar
• Katsanis SH, Javitt G, Hudson K. Public health. A case study of personalized medicine. Science. 2008;320:53–54. Erratum in Science. 2008;320(5874):316.
   Google Scholar
• Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacol Rev. 1988;40:243–288.
   PubMed Web of Science ®Google Scholar
• Bird A. Perceptions of epigenetics. Nature. 2007;447(7143):396–398.
   PubMedGoogle Scholar
• Feldman SR, Horn EJ, Balkrishnan R, Basra MK, Finlay AY, McCoy D, Psoriasis: Improving adherence to topical therapy. J Am Acad Dermatol. 2008;59(6):1009–1016.
   PubMed Web of Science ®Google Scholar
• Carroll CL, Feldman SR, Camacho FT, Balkrishnan R. Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol. 2004;151(4):895–897.
   PubMedGoogle Scholar
• Lott R, Taylor SL, O'Neill JL, Krowchuk DP, Feldman SR. Medication adherence among acne patients: A review. Br J Dermatol. 2004;151(4):895–897.
   PubMedGoogle Scholar
• Conde JF, Kaur M, Fleischer AB Jr, Tusa MG, Camacho F, Feldman SR. Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis. Cutis. 2008;81(5):435–441.
   PubMedGoogle Scholar
• Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D, Stealth monitoring of adherence to topical medication: Adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56(2):211–216.
   PubMedGoogle Scholar
• Jarrold B, Mullins L, Reichling T, Osborne R. Expression of stratum corneum lipid pathways in human skin equivalent cultures. J Am Acad Dermatol. 2008;58(2):AB30.
   Google Scholar
• Saaf AM, Tengvall-Linder M, Chang HY, Adler AS, Wahlgren CF, Global expression profiling in atopic eczema reveals reciprocal expression of inflammatory and lipid genes. PLoS One. 2008;3(12):e4017.
   Google Scholar
• Osborne R, Mullins LA, Jarrold BB. Understanding metabolic pathways for skin anti-aging. J Drugs Dermatol. 2009;8(7 suppl):s4–7.
   PubMedGoogle Scholar
• Khavari PA. Modeling cancer in human skin tissue. Nat Rev Cancer. 2006;4(6):270–280.
   Google Scholar
• Robinson MK, Binder RL, Griffiths CE. Genomic-driven insights into changes in aging skin. J Drugs Dermatol. 2009;8(7 suppl):s8–11.
   Google Scholar
• Bissett DL, Farmer T, McPhail S, Reichling T, Tiesman JP, Juhlin KD, Genomic expression changes induced by topical N-acetyl glucosamine in skin equivalent cultures in vitro. J Cosmet Dermatol. 2007;6(4):232–238.
   PubMedGoogle Scholar
• Mullins L, Jarrold B, Linter K, Osborne R. In vitro skin biomarker responses to a new anti-aging peptide, Pal-KT. J Am Acad Dermatol. 2009;60(suppl):AB82.
   Google Scholar